Original ResearchPredictors of Lower Extremity Amputation and Reamputation Associated With the Diabetic Foot
Section snippets
Patients and Methods
We performed a retrospective review of the records of 132 consecutive patients who had undergone lower extremity amputation or reamputation as a result of diabetic wounds at Konya Necmettin Erbakan University Meram Medical Faculty Hospital from January 2013 to March 2016. Two surgeons (E.A., B.K.K.) performed all record reviews and surgeries. All the patients provided written informed surgical consent. The institutional review board approved our study protocol, and the study was conducted in
Results
The mean follow-up period of the patients was 20 (range 14 to 27) months. Of 132 patients, 110 had undergone an initial amputation and 22, a reamputation (Table 1). The mean age of all the patients was 64.3 (range 27 to 89) years. Of the 132 patients, 90 were male and 42 were female. The mean diabetes duration was 10.5 years in the amputation group and 11.5 years in the reamputation group. Of the 132 patients, 20 had culture-positive wound infections (Fig. 1, Fig. 2), and 18 had culture
Discussion
In our study, the significant predictors for either amputation or reamputation were similar. The strongest predictors for requiring surgery in both groups were male gender, longer diabetes duration, wound infection, diabetic neuropathy, and positive smoking history. The ORs for each of these comorbidities in the amputation group were generally greater than the ORs in the reamputation group. Tükenmez et al (10) identified hypertension, coronary artery disease, and leukocytosis as the most common
References (23)
- et al.
Outcomes following advanced wound care for diabetic foot ulcers: a Canadian study
Can J Diabetes
(2017) - et al.
Diabetic foot ulcer development risk classifications' validation: a multicentre prospective cohort study
Diabetes Res Clin Pract
(2017) - et al.
The impact of diabetes related lower-extremity amputations in the Netherlands
J Intern Med
(1996) - et al.
A meta-analysis of long-term mortality and associated risk factors following lower extremity amputation
Ann Vasc Surg
(2017) - et al.
Amputation risk in patients with diabetes mellitus and peripheral artery disease using statewide data
Ann Vasc Surg
(2016) - et al.
The incidence and risks of failure to heal after lower extremity amputation for the treatment of diabetic neuropathic foot ulcer
J Foot Ankle Surg
(2006) - et al.
Clinical reliability and utility of skin perfusion pressure measurement in ischemic limbs—comparison with other noninvasive diagnostic methods
J Vasc Surg
(2008) - et al.
Procalcitonin as a biomarker for predicting amputation level in lower extremity infections
J Foot Ankle Surg
(2017) - et al.
Orv Hetil
(2017) - et al.
Foot ulcer risk is lower in South-Asian and American Caribbean compared with European diabetic patients in the UK: the Northwest Diabetes Foot Care Study
Diabetes Care
(2005)
Losing a foot versus losing a dollar: a systematic review of cost studies in diabetic foot complications
Expert Rev Pharmacoecon Outcomes Res
Cited by (46)
Morbidity and Mortality of the Transmetatarsal Amputation: A Comparative NSQIP Analysis
2024, Journal of Foot and Ankle SurgeryThou shall not heal: Overcoming the non-healing behaviour of diabetic foot ulcers by engineering the inflammatory microenvironment
2023, Advanced Drug Delivery ReviewsRisk factors for reamputation in patients with diabetic foot: A case-control study
2023, Foot and Ankle SurgeryRacial, ethnic, and socioeconomic inequities in amputation risk for patients with peripheral artery disease and diabetes
2023, Seminars in Vascular SurgeryInternal Iliac Artery Patency as a Predictor of Above-Knee Amputation Stump Healing
2023, Annals of Vascular Surgery
Financial Disclosure: None reported.
Conflict of Interest: None reported.